US Stock MarketDetailed Quotes

ALRN Aileron Therapeutics

Watchlist
  • 3.7000
  • -0.0700-1.86%
Close May 22 16:00 ET
79.88MMarket Cap-1145P/E (TTM)

Aileron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
80.62%7.21M
-44.49%15.35M
55.26%7.3M
-69.50%1.98M
-74.13%2.08M
-52.63%3.99M
3.92%27.65M
-31.00%4.7M
-4.55%6.48M
33.82%8.04M
Selling and administrative expenses
71.73%3.74M
17.32%11.36M
131.64%5.33M
-12.84%1.96M
-27.42%1.89M
-13.81%2.18M
0.86%9.68M
2.04%2.3M
-10.74%2.24M
20.96%2.61M
-General and administrative expense
71.73%3.74M
17.32%11.36M
131.64%5.33M
-12.84%1.96M
-27.42%1.89M
-13.81%2.18M
0.86%9.68M
2.04%2.3M
-10.74%2.24M
20.96%2.61M
Research and development costs
91.33%3.46M
-77.79%3.99M
-17.90%1.97M
-99.48%22K
-96.56%187K
-69.29%1.81M
5.64%17.97M
-47.34%2.4M
-0.91%4.24M
41.01%5.43M
Operating profit
-80.62%-7.21M
44.49%-15.35M
-55.26%-7.3M
69.50%-1.98M
74.13%-2.08M
52.63%-3.99M
-3.92%-27.65M
31.00%-4.7M
4.55%-6.48M
-33.82%-8.04M
Net non-operating interest income expense
400K
78K
40.91%155K
128.57%112K
423.81%110K
157.89%49K
Non-operating interest income
----
--400K
--78K
40.91%155K
128.57%112K
----
----
----
423.81%110K
157.89%49K
Other net income (expense)
111.65%92K
-328.93%-728K
-117.56%-59K
-225.00%-5K
181K
-3,490.91%-790K
-27.89%318K
373.24%336K
-93.94%4K
Gain on sale of security
----
--200K
----
----
----
----
----
----
----
----
Special income (charges)
--0
---928K
--12K
---6K
--88K
---1.02M
--0
--0
--0
--0
-Less：Restructuring and merger&acquisition
--0
--928K
---12K
--6K
---88K
--1.02M
--0
--0
--0
--0
Other non- operating income (expenses)
-60.34%92K
----
----
-75.00%1K
--93K
1,154.55%232K
-27.89%318K
373.24%336K
-93.94%4K
----
Income before tax
-48.84%-7.11M
42.64%-15.68M
-60.17%-7.28M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
5.01%-6.37M
-40.56%-7.99M
Income tax
Net income
-48.84%-7.11M
42.64%-15.68M
-60.17%-7.28M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
5.01%-6.37M
-40.56%-7.99M
Net income continuous Operations
-48.84%-7.11M
42.64%-15.68M
-60.17%-7.28M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
5.01%-6.37M
-40.56%-7.99M
Minority interest income
Net income attributable to the parent company
-48.84%-7.11M
42.43%-15.73M
-61.40%-7.34M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
5.01%-6.37M
-40.56%-7.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-48.84%-7.11M
42.43%-15.73M
-61.40%-7.34M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
5.01%-6.37M
-40.56%-7.99M
Basic earnings per share
18.10%-0.86
43.19%-3.42
-57.00%-1.57
71.43%-0.4
77.84%-0.39
43.55%-1.05
-2.21%-6.02
32.89%-1
0.00%-1.4
-46.67%-1.76
Diluted earnings per share
18.10%-0.86
43.19%-3.42
-57.00%-1.57
71.43%-0.4
77.84%-0.39
43.55%-1.05
-2.21%-6.02
32.89%-1
0.00%-1.4
-46.67%-1.76
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 80.62%7.21M-44.49%15.35M55.26%7.3M-69.50%1.98M-74.13%2.08M-52.63%3.99M3.92%27.65M-31.00%4.7M-4.55%6.48M33.82%8.04M
Selling and administrative expenses 71.73%3.74M17.32%11.36M131.64%5.33M-12.84%1.96M-27.42%1.89M-13.81%2.18M0.86%9.68M2.04%2.3M-10.74%2.24M20.96%2.61M
-General and administrative expense 71.73%3.74M17.32%11.36M131.64%5.33M-12.84%1.96M-27.42%1.89M-13.81%2.18M0.86%9.68M2.04%2.3M-10.74%2.24M20.96%2.61M
Research and development costs 91.33%3.46M-77.79%3.99M-17.90%1.97M-99.48%22K-96.56%187K-69.29%1.81M5.64%17.97M-47.34%2.4M-0.91%4.24M41.01%5.43M
Operating profit -80.62%-7.21M44.49%-15.35M-55.26%-7.3M69.50%-1.98M74.13%-2.08M52.63%-3.99M-3.92%-27.65M31.00%-4.7M4.55%-6.48M-33.82%-8.04M
Net non-operating interest income expense 400K78K40.91%155K128.57%112K423.81%110K157.89%49K
Non-operating interest income ------400K--78K40.91%155K128.57%112K------------423.81%110K157.89%49K
Other net income (expense) 111.65%92K-328.93%-728K-117.56%-59K-225.00%-5K181K-3,490.91%-790K-27.89%318K373.24%336K-93.94%4K
Gain on sale of security ------200K--------------------------------
Special income (charges) --0---928K--12K---6K--88K---1.02M--0--0--0--0
-Less：Restructuring and merger&acquisition --0--928K---12K--6K---88K--1.02M--0--0--0--0
Other non- operating income (expenses) -60.34%92K---------75.00%1K--93K1,154.55%232K-27.89%318K373.24%336K-93.94%4K----
Income before tax -48.84%-7.11M42.64%-15.68M-60.17%-7.28M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M5.01%-6.37M-40.56%-7.99M
Income tax
Net income -48.84%-7.11M42.64%-15.68M-60.17%-7.28M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M5.01%-6.37M-40.56%-7.99M
Net income continuous Operations -48.84%-7.11M42.64%-15.68M-60.17%-7.28M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M5.01%-6.37M-40.56%-7.99M
Minority interest income
Net income attributable to the parent company -48.84%-7.11M42.43%-15.73M-61.40%-7.34M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M5.01%-6.37M-40.56%-7.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -48.84%-7.11M42.43%-15.73M-61.40%-7.34M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M5.01%-6.37M-40.56%-7.99M
Basic earnings per share 18.10%-0.8643.19%-3.42-57.00%-1.5771.43%-0.477.84%-0.3943.55%-1.05-2.21%-6.0232.89%-10.00%-1.4-46.67%-1.76
Diluted earnings per share 18.10%-0.8643.19%-3.42-57.00%-1.5771.43%-0.477.84%-0.3943.55%-1.05-2.21%-6.0232.89%-10.00%-1.4-46.67%-1.76
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg